Samsung Biologics to tout upcoming ADC plant at biotech expo

Samsung Biologics will attempt to lure clients with its soon-to-open plant for antibody-drug conjugates, a promising next-generation cancer treatment, at BioPlus Interphex Korea 2024.

Samsung Biologics' booth at the BioPlus Interphex Korea 2024, which is set to kick off on Wednesday at Coex in southern Seoul. [SAMSUNG BIOLOGICS]

Samsung Biologics seeks to lure prospective clients with its soon-to-open plant for antibody-drug conjugate (ADC) therapies, a promising next-generation cancer treatment, at BioPlus Interphex Korea 2024 kicking off on Wednesday.

It marks first time the Korean company will open a booth at the annual three-day trade show, the country's largest biotechnology exhibition running under the theme "The World's Tangible Bio-healthcare Convention," the company said Tuesday.

Samsung Biologics’ booth will highlight its contract development and manufacturing organization capabilities, including its world-leading manufacturing capacity, which will reach 1.3 million liters (343,000 gallons) by 2032. The company currently has four plants in Songdo, Incheon, and plans to operate four more there.

The company will also introduce its competitiveness in ADC, which has been touted as next-level technology in cancer treatment. Consisting of an antibody, linker and payload, ADC delivers chemotherapy agents selectively to cancer cells while sparing healthy ones — earning it the nickname “biological missile” or the “magic bullet.”

"Samsung aims to lure potential clients to our ADC-dedicated plant in Songdo, Incheon, which is set to be completed by December," the company said in a statement.

Lim Heon-chang, director of formulation development at Samsung Biologics, is also scheduled to give a speech on the successful development of new drugs using Developick, Samsung's new platform dedicated to discovering new drug candidates.

Co-hosted by KoreaBio and Reed Exhibitions Korea, the event at Coex in southern Seoul will be attended by 250 firms and is expected to attract around 10,000 visitors.

BY SARAH CHEA [chea.sarah@joongang.co.kr]